Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia

Clinical trial NCT04507971 · UNKNOWN

Trial details

NCT number: NCT04507971
Sponsor: NuBiyota
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Obesity, Metabolically Benign

Start date: 2020-06-22
Primary completion: 2021-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.